Hironobu Hata

7PUBLICATIONS
10CO-AUTHORS
ChemotherapyPredictive and prognostic markersFood properties (incl. characteristics and health benefits)Traditional Chinese medicine and treatmentsPhylogeny and comparative analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 14, 2026
Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study.

Hironobu Hata, Kenji Imamachi, Kazuhito Yoshikawa

|Nov 01, 2022
Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points.

Hironobu Hata, Kenji Imamachi, Michihiro Ueda

|Mar 04, 2022
Oral adverse events due to zinc deficiency after pancreaticoduodenectomy requiring continuous intravenous zinc supplementation: a case report and literature review.

Hironobu Hata, Yojiro Ota, Katsuhiko Uesaka

|Feb 03, 2022
Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.

Hironobu Hata, Kenji Imamachi, Michihiro Ueda

|Mar 18, 2021
Analgesic effects of indomethacin spray on drug-induced oral mucositis pain in patients with cancer: A single-arm cross-sectional study.

Hironobu Hata, Shinya Takada, Jun Sato

|Oct 16, 2020
Quantitative bone single photon emission computed tomography analysis of the effects of duration of bisphosphonate administration on the parietal bone.

Hironobu Hata, Tomoka Kitao, Jun Sato

Pageof 2

Frequent Collaborators

4 joint publications

Kenji Imamachi

3 joint publications

Masashi Matsuzaka

3 joint publications

Toshihisa Osanai

2 joint publications

Masato Takahashi